SEC 13F Intelligence

Altium Capital Management LLC / SRPT

Altium Capital Management LLC’s Sarepta Therapeutics Inc Position

Does Altium Capital Management LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 127.0K shares worth $15M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q4 2024
Shares
127.0K
% of Portfolio
+4.38%
Quarters Held
5
position exited

Position History SRPT

Reported value by quarter
Q2 ’23: $3MQ2 ’23Q3 ’23: $4MQ3 ’23Q2 ’24: $13MQ2 ’24Q3 ’24: $21MQ3 ’24Q4 ’24: $15MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024127.0K$15M+4.38%
Q3 2024170.0K$21M+6.25%
Q2 202481.9K$13M+5.28%
Q3 202329.3K$4M+1.85%
Q2 202328.0K$3M+2.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of SRPT.